Date Insider Type Main position Quantity % Market Cap. Importance
8/28/20 Tax

General Counsel

997 0.0007%
8/28/20 Tax

Executive/Senior Manager

281 0.0002%
8/28/20 Tax

Chief Financial Officer

256 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-10.00% - - 3.6M
-1.61%+1.72%+38.30%+106.93% 1,060B
-0.76%-0.84%+35.21%+62.70% 623B
+0.39%+4.81%+17.81%+83.77% 480B
-0.29%-0.99%+64.79%+37.06% 352B
-2.03%+1.03%+22.25%+42.16% 345B
-1.92%-1.87%+11.94%+33.20% 274B
-2.36%-3.16%-6.95%+8.68% 249B
-1.37%+0.04%+38.29%+52.33% 223B
+0.17%-0.27%+24.40%+96.82% 182B
Average -0.89%-0.48%+27.34%+58.18% 420.89B
Weighted average by Cap. -1.05%+0.04%+30.65%+68.82%
Logo Akorn, Inc.
Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
Employees
-
  1. Stock Market
  2. Stocks
  3. AKRXQ Stock